Deep-learning perturbation models can outperform baselines on calibrated metrics

Nature Biotechnology says deep-learning perturbation models can outperform baselines on calibrated metrics. It also linked to a Shift Bioscience announcement claiming the company’s publication builds confidence in AI virtual cells for novel target discovery.